Vios Medical represents leading entry into medical technology industry
Vios Medical, Inc., a medical technology company that develops patient-monitoring sensors and software, has been acquired by stakeholder Murata Manufacturing Co. Ltd. The transaction closed successfully on October 13, 2017.
“The completion of this transaction represents a significant step forward for Vios Medical in our vision of creating an industry leading medical technology that dramatically reduces the costs and improves the quality of healthcare delivery domestically and globally,” said Amit Patel, co-founder and CEO of Vios Medical. “Through the marriage of our companies, we look forward to accelerating our product development efforts and the realization of the economical and clinical value that our solution brings to the market.”
The Vios monitoring system is designed to optimize the management of patients through the continuum of care providing a user-friendly, lower-cost and more efficient patient monitoring and care coordination platform than existing options. Utilizing sensors, unique signal processing IP, and propriety software that runs on standard off-the-shelf hardware, Vios medical can track patient vital signs on a variety of standard mobile devices, tablets, and computers. Healthcare providers will be able to monitor patient data in near real-time from any location without the enormous dependence on expensive hospital IT infrastructure.
The second generation Vios chest sensor collects seven-lead ECG, heart rate, respiratory rate, oxygen saturation, blood pressure, patient temperature, pulse rate, and movement data. The first generation Vios Monitoring System received 510(k) clearance in 2016 and the second generation system is currently being reviewed by the FDA. The system has been commercially launched at world renowned hospitals in India and is currently being piloted in US hospitals today.